Skip to content
healthcare.dev

Liothyronine Sodium

NDC 59762-1208, liothyronine sodium, tablet, from Mylan Pharmaceuticals Inc..

Product NDC
59762-1208
Status
Listed
Labeler
Mylan Pharmaceuticals Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA010379
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/59762-1208 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • LIOTHYRONINE SODIUM50 ug/1

Pharmacologic classes

Triiodothyronine [CS]; l-Triiodothyronine [EPC]

Package NDCNDC-11Package
59762-1208-159762120801100 TABLET in 1 BOTTLE (59762-1208-1)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/115a84c2-0126-4dd7-816e-1873875f1e49
  • NADAC price for package 59762120801

    GET /v1/drugs/nadac/59762120801

Use it

Look up 59762-1208 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/59762-1208 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 59762-1208. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.